Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures

S. A. Rangarajan, Dileep Ramachandran, Tanaya Mishra, Vikneshwaran Gunaseelan, Gopal K. Dash, Vivek J. Philip, Radhika Manohar, Kuldeep Shetty, Pavin Thomas, V. Huded
{"title":"Endovascular Treatment for Cerebral Venous Sinus Thrombosis: Comparison among Different Endovascular Procedures","authors":"S. A. Rangarajan, Dileep Ramachandran, Tanaya Mishra, Vikneshwaran Gunaseelan, Gopal K. Dash, Vivek J. Philip, Radhika Manohar, Kuldeep Shetty, Pavin Thomas, V. Huded","doi":"10.4103/aian.aian_965_23","DOIUrl":null,"url":null,"abstract":"\n \n \n Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes.\n \n \n \n This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization.\n \n \n \n Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache (n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia (n = 13, 25.5%) and hyperhomocysteinemia (n = 13, 25.5%). Worsening of sensorium (n = 21, 40.3%) and non-improvement of symptoms (n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures (P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome (P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge.\n \n \n \n EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.\n","PeriodicalId":504920,"journal":{"name":"Annals of Indian Academy of Neurology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Indian Academy of Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/aian.aian_965_23","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Cerebral venous sinus thrombosis (CVST) is a rare, treatable cause of stroke. Even though CVST has an established medical treatment, 15% of patients remain refractory to treatment. These patients may be candidates for endovascular treatment (EVT), yet the selection of patients remains a challenge. The study aims to understand the profile and outcome of patients treated with EVT and the type of procedure associated with good outcomes. This is a single-center, retrospective analysis of CVST patients who underwent EVT from 2009 till 2022. Patients who received only medical management were excluded. Modified Rankin Scale (mRS) ≤2 at 3 months was taken as the primary outcome. Secondary outcomes assessed were hospital stay, death, recurrence, mRS ≤ 2 at discharge, and angiographic recanalization. Fifty-two patients were included. Twenty-eight (53.8%) were males; the mean age was 33.3 ± 12.3 years. Headache (n = 44, 84.6%) predominated among the symptoms. The common risk factors were anemia (n = 13, 25.5%) and hyperhomocysteinemia (n = 13, 25.5%). Worsening of sensorium (n = 21, 40.3%) and non-improvement of symptoms (n = 15, 28.8%) were the common indications for the procedure. Twenty-five (48.1%) people underwent in situ thrombolysis (IST). Death occurred in eight (15.3%) patients. Thirty-six (73.5%; 36/49) patients had a good outcome at 3 months. IST had a significantly better outcome (mRS ≤ 2, n = 20, 80%) compared to other procedures (P = 0.04). Hospital stay was lesser in the IST subgroup, but without statistical significance. Midline shift >5 mm (odds ratio [OR] 6.8 [1.5–30.9], P = 0.01) and Glasgow Coma Scale <9 before the procedure (OR 27.2 [3.1–236.4], P = 0.002) predicted bad outcomes at 3 months. Female gender (OR 4.5 [1.07–8.8], P = 0.03), presence of altered sensorium (OR 10.2 [1.2–87.5], P = 0.01), encephalopathic syndrome (P = 0.02), presence of parenchymal bleed (OR 3.7 [0.9–4.5], P = 0.04), and midline shift (OR 4.8 [1.1–20.2], P = 0.03) were associated with poor outcome at discharge. EVT yielded good outcomes in carefully selected, medically refractory patients of CVST. IST performed well compared to other procedures.
脑静脉窦血栓的血管内治疗:不同血管内手术的比较
脑静脉窦血栓形成(CVST)是一种罕见的、可治疗的脑卒中病因。尽管 CVST 已有成熟的药物治疗方法,但仍有 15% 的患者难治。这些患者可能适合接受血管内治疗(EVT),但患者的选择仍是一个难题。本研究旨在了解接受 EVT 治疗的患者的概况和疗效,以及与良好疗效相关的手术类型。 这是一项对 2009 年至 2022 年期间接受 EVT 治疗的 CVST 患者进行的单中心回顾性分析。仅接受药物治疗的患者不包括在内。3个月时改良朗肯量表(mRS)≤2为主要评估结果。次要评估结果包括住院时间、死亡、复发、出院时 mRS ≤ 2 以及血管造影再通。 共纳入 52 名患者。男性28人(53.8%),平均年龄(33.3 ± 12.3)岁。症状以头痛为主(44 人,占 84.6%)。常见的风险因素是贫血(13 人,占 25.5%)和高同型半胱氨酸血症(13 人,占 25.5%)。感觉恶化(21 人,40.3%)和症状无改善(15 人,28.8%)是手术的常见适应症。25人(48.1%)接受了原位溶栓治疗(IST)。8名患者(15.3%)死亡。36名(73.5%;36/49)患者在3个月后疗效良好。与其他手术相比,IST的疗效明显更好(mRS ≤ 2,n = 20,80%)(P = 0.04)。IST 亚组的住院时间较短,但无统计学意义。中线移位 >5 mm(几率比 [OR] 6.8 [1.5-30.9],P = 0.01)和术前格拉斯哥昏迷量表 <9(OR 27.2 [3.1-236.4],P = 0.002)预示着 3 个月后的不良后果。女性性别(OR 4.5 [1.07-8.8],P = 0.03)、感觉改变(OR 10.2 [1.2-87.5],P = 0.01)、脑病综合征(P = 0.02)、实质出血(OR 3.7 [0.9-4.5],P = 0.04)和中线移位(OR 4.8 [1.1-20.2],P = 0.03)与出院时的不良预后有关。 对于经过精心挑选、药物难治的 CVST 患者,EVT 取得了良好的疗效。与其他手术相比,IST效果良好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信